- Abstract
- Core Tip
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (119)
- Timeline of Article Publication (0)
- Authors Evaluation (2)
- Article Quality Tracking (0)
- Reference Citation Analysis (3)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2311)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 15, 2024 (publication date) through Apr 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lei XT, Pu DL, Shan G, Wu QN. Atorvastatin ameliorated myocardial fibrosis by inhibiting oxidative stress and modulating macrophage polarization in diabetic cardiomyopathy. World J Diabetes 2024; 15(6): 1070-1073 [PMID: 38983803 DOI: 10.4239/wjd.v15.i6.1070] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i6/1070.htm |
| Number | Citing Articles |
| 1 |
Hongbing Wan, Xiuxiu Xu, Dasong Yi, Kexin Shuai. Real-world safety evaluation of atorvastatin: insights from the US FDA adverse event reporting system (FAERS). Expert Opinion on Drug Safety 2025; 24(3): 305 doi: 10.1080/14740338.2024.2424438
|